当前位置: 首页 > 期刊 > 《中国医学创新》 > 201811
编号:13590601
p53、β—连环蛋白与IL—10联合检测对EB病毒相关性胃癌患者的预后评估的临床研究(4)
http://www.100md.com 2018年4月15日 《中国医学创新》 201811
     [13] Sivachandran N,Dawson C W,Young L S,et al.Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma[J].Journal of Virology,2012,86(1):60-68.

    [14] Yaguchi T,Goto Y,Kido K,et al.Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells[J].Journal of Immunology,2012,189(5):2110-2117.

    [15]舒君.EB病毒感染對IGF2基因甲基化和印迹表达影响的研究[D].青岛:青岛大学,2016.

    [16] Wang L,Wang Q T,Liu Y P,et al.ATM Signaling Pathway Is Implicated in the SMYD3-mediated Proliferation and Migration of Gastric Cancer Cells[J].Journal of Gastric Cancer,2017,17(4):295.

    [17] Huang H,Han Y,Yang X,et al.HNRNPK inhibits gastric cancer cell proliferation through p53/p21/CCND1 pathway[J].Oncotarget,2017,8(61):103364-103374.

    [18] Chen L,Tang J,Feng Y,et al.ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling[J].Cell Physiol Biochem,2017,44(4):1370-1380., 百拇医药(汪维佳 廖志波)
上一页1 2 3 4